background: patients with parkinson's disease (pd) have different cognitive impairments.the goal of this study is the analysis of these changes in the mentioned patients.a cross-sectional study was performed on 87 patients with pd. patients were given a questionnaire to gather data about their medical and living statuses. to assess cognitive assessment, scopa-cog (scales for outcome in parkinso...

OBJECTIVE To investigate whether serum vitamin D level predicts the risk of Parkinson disease. DESIGN Cohort study. SETTING The study was based on the Mini-Finland Health Survey, which was conducted from 1978 to 1980, with Parkinson disease occurrence follow-up through the end of 2007. During the 29-year follow-up period, 50 incident Parkinson disease cases occurred. Serum 25-hydroxyvitamin...

Segundo a portaria n° 228, de 10 maio 2010 do Ministério da Saúde, doença Parkinson (DP), antes descrita por James em 1817, é uma das doenças neurológicas mais comuns e intrigantes atualidade. A patologia caracterizada quatro sinais clínicos essenciais: Tremor repouso, rigidez, bradicinesia instabilidade postural. O presente estudo avaliou importância atuação fisioterapia na Parkinson, buscando...

Committee of the European Academy of Neurology in Brussels, Belgien. He is also a member of the high level advisory board for the European Ministry for Research and Development " Scientific Panel for Health (SPH) ". He has received many prestigious awards during his career, including the " carrier award for basal ganglia disorders " On the International Conference: Clinical Update Sleep 2016, w...

Mutations in GBA, the gene encoding glucocerebrosidase, the enzyme deficient in Gaucher disease, are common risk factors for Parkinson disease, as patients with Parkinson disease are over five times more likely to carry GBA mutations than healthy controls. Patients with GBA mutations generally have an earlier onset of Parkinson disease and more cognitive impairment than those without GBA mutati...

after alzheimer disease, parkinson disease (pd) is considered the most common neurodegenerative disease. its prevalence is the same in all area but it is common in males than females. from every 100 persons who are above 60 years old, one of them has pd. also 5-10% of patients are less than 40 years old. this progressive neuroinflammation disease isn’t fatal. in 60% of cases is with depression....

normal 0 false false false en-us x-none ar-sa background: t he study on transcranial sonocraphy (tcs) as a diagnostic test for parkinson’s disease (pd) has been neglected in some hospitals. the current study was conducted as the first study to investigate the utility of tcs for diagnosis of pd and its ability to distinguish pd from essential tremor (et) in an iranian population. materials and m...

BACKGROUND AND PURPOSE The pathology of Parkinson disease leads to morphological brain volume changes. So far, the progressive gray matter volume change across time specific to patients with Parkinson disease compared controls remains unclear. Our aim was to investigate the pattern of gray matter changes in patients with Parkinson disease and to explore the progressive gray matter volume change...

BACKGROUND AND PURPOSE Standard neuroimaging fails in defining the anatomy of the substantia nigra and has a marginal role in the diagnosis of Parkinson disease. Recently 7T MR target imaging of the substantia nigra has been useful in diagnosing Parkinson disease. We performed a comparative study to evaluate whether susceptibility-weighted angiography can diagnose Parkinson disease with a 3T sc...

BACKGROUND Sex differences in Parkinson disease clinical features have been reported, but few studies have examined sex influences on use of dopaminergic medication in early Parkinson disease. The objective of this study was to test if there are differences in the type of dopaminergic medication used and levodopa equivalent daily dose between men and women with early Parkinson disease enrolled ...